M. Meinz - Concepedia

Author

M. Meinz

Also Known As

M Meinz, M. MEINZ, M. Meinz, M. S. MEINZ, MariaS. Meinz

Publications

827

Citations

H-Index

Concepts

All Affiliations

M. Meinz is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicine, and natural sciences.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	701
2	Natural Sciences	2	2	365
3	Biochemistry	2	2	365
4	Engineering	1	1	336
5	Chemical Biology	1	1	52

M. Meinz

Publications

827

Citations

H-Index

Page 1

	Year	Citations
Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors Cameron Douglas, Joseph A. D'Ippolito, G.-J. Shei, Antimicrobial Agents and Chemotherapy EngineeringGlycobiologyMolecular BiologyFks1 GeneDrug Resistance	1997	336
Discovery of Novel Antifungal (1,3)-β- <scp>d</scp> -Glucan Synthase Inhibitors Janet C. Onishi, M. Meinz, John R. Thompson, Antimicrobial Agents and Chemotherapy Medicinal ChemistryBiosynthesisAntimicrobial Drug DiscoveryAntifungal AgentBiochemistry	2000	313
Antimicrobial activity of ergokonin A from Trichoderma longibrachiatum M. Francisca Vicente, Angeles Cabello, Gonzalo Platas, Journal of Applied Microbiology	2001	53
Chaetomella acutiseta produces chaetomellic acids A and B which are reversible inhibitors of farnesyl-protien transferase R. B. Lingham, KeithC. Silverman, Gerald F. Bills, Applied Microbiology and Biotechnology Inhibitory ActivityFarnesyl-protien TransferaseBioorganic ChemistryBiochemistryChaetomella Acutiseta	1993	52
Antimicrobial Activity of Viridiofungins. Janet C. Onishi, James A. Milligan, Ángela Basilio, The Journal of Antibiotics	1997	39
A NOVEL INOSITOL MONO-PHOSPHATASE INHIBITOR FROM Memnoniella echinata Y. K. TONY LAM, C. F. WICHMANN, M. Meinz, The Journal of Antibiotics	1992	34

Page 1